Scientists from the University of Queensland and experts from Botanix Pharmaceuticals Limited (an Australian pharmaceutical company that studies synthetic cannabinoids. -
Plus-one.ru) made a discovery that could lead to the creation of powerful new antibiotics, the likes of which have not been seen in 60 years. The research is published in the journal Communications Biology.
Experts have found that CBD (synthetic cannabidiol, a non-psychoactive compound derived from cannabis - Plus-one.ru) can kill bacteria that cause gonorrhea, meningitis and Legionnaires' disease (an infectious disease that leads to severe pneumonia. - Plus-one.ru)). At the same time, even a high concentration of cannabidiol did not cause resistance in bacteria.
It is known that resistant bacteria have an additional membrane, the so-called biofilm. This helps them to survive, since with such a cell structure it is difficult for antibiotics to penetrate inside. Cannabidiol has managed to destroy these membranes, which opens up a great future for it, scientists say. The study found that CBD was just as effective against antibiotic-resistant gram-positive bacteria like Staphylococcus aureus.
As a reminder, in November 2019, the UK authorities authorized a cannabis drug because, in their opinion, its active ingredient cannabidiol can treat epilepsy and multiple sclerosis. Marijuana medicine was used to treat stress in elephants at Warsaw Zoo. Last December, the UN removed marijuana from the list of dangerous drugs such as heroin, which will allow research and the use of marijuana for medical purposes. But Russia voted against.]]>